Financial Performance - The company's net profit attributable to shareholders is expected to be between 100 million and 120 million CNY, representing a decline of 59.95% to 66.62% compared to the previous year's profit of 299.59 million CNY[2] - The net profit after deducting non-recurring gains and losses is projected to be between 95 million and 115 million CNY, a decrease of 60.12% to 67.06% from the previous year's 288.38 million CNY[2] Revenue Challenges - The decline in orders is attributed to client budget adjustments in "electronic payment" and "integrated fiscal budget management," leading to a decrease in revenue from these areas[4] - The lengthening of settlement and payment cycles for major clients has resulted in increased bad debt provisions, negatively impacting current profit levels[4] New Business Ventures - The company is entering new fields such as medical insurance and digital invoices, but has not yet achieved significant revenue in these areas for the fiscal year[4] R&D Investment - The company is maintaining high investment in R&D for digital finance, digital invoices, medical insurance, and digital trademarks, with R&D expenses expected to grow compared to 2023[5]
中科江南(301153) - 2024 Q4 - 年度业绩预告